About Us

Gyroscope Therapeutics Ltd is a private company founded by Syncona and Cambridge Enterprise and supported by its scientific founders with expertise in ophthalmology, immunology and gene therapy.

Our mission is to develop genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system.

Our management and scientific teams have extensive experience in gene therapy and drug development, particularly in the field of ophthalmology, and have served in leadership roles at several innovative pharmaceutical companies.

The company is headquartered in Hertfordshire, UK.